Younong Xu

A Low-Molecular-Weight Inhibitor against the Chemokine Receptor CXCR4: A Strong Anti-HIV Peptide T140

Hirokazu Tamamura, Younong Xu, Toshio Hattori et al. · Biochemical and Biophysical Research Communications · 1998 · 305 citations

Low-molecular-weight Inhibitor, Medicine, Human Retrovirus +9

Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140

Hirokazu Tamamura, Akane Omagari, Kenichi Hiramatsu et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 109 citations · Full text

Medicine, Human Retrovirus, High Selectivity Indexes +10

Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients

Michael A. Morse, Arvind Chaudhry, Elizabeth S. Gabitzsch et al. · Cancer Immunology Immunotherapy · 2013 · 90 citations · Full text

Cancer Immunosurveillance, Anti-adenoviral Neutralizing Antibodies, Immunology +9

Most Highly Exposed Seronegative Men Lack HIV-1-Specific, IFN-γ-Secreting T Cells

Florian Hladik, Anthony L. Desbien, Jean Lang et al. · The Journal of Immunology · 2003 · 55 citations

Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer

Joseph P. Balint, Elizabeth S. Gabitzsch, Adrian Rice et al. · Cancer Immunology Immunotherapy · 2015 · 53 citations · Full text

Phase 1/2, Extended Evaluation, Medicine +9